An underground economy for unapproved slimming drugs is propelled by social media fitness personalities and vendors on communication apps, according to new investigations.
Investigational Treatment Acquiring Popularity Online
Retatrutide, which remains in research studies, is being promoted by social media influencers for its supposed weight-reducing properties. Viewers are urged to contact these profiles privately for supplier links, while also receiving discount codes.
Thriving Trade on Messaging Platforms
Additionally, a flourishing trade exists on messaging services, where communities with thousands of participants share comparison images, injection guides and assertions of next-day UK delivery. Sellers promote the drug there before directing customers to WhatsApp for purchases.
Understanding Retatrutide
This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could help individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.
Healthcare Professionals Voice Worries
Nevertheless, physicians and chemists have warned that the sale of what is still an unlicensed medication in the United Kingdom is worrisome and could lead to individuals injecting substances of unknown origin.
Several professionals said the demand for retatrutide could be connected to the increasing cost of licensed slimming products such as Mounjaro.
Legal Position and Enforcement
Selling retatrutide on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.
Several influencers attempt to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still breach medicines, advertising, and customer laws, potentially leading to fines, legal action or imprisonment.
Platform Reaction and Material Elimination
Based on TikTok, the service has taken down problematic material and prohibited related keywords and query recommendations. The company stated it was committed to keeping the service safe and investing in enhancing compliance measures.
Online Marketplace Activities
Research also found groups with up to 9,000 participants selling the experimental drug using Telegram's integrated search feature, which operates like a public directory. Typing “retatrutide” instantly displays groups with thousands of members, filled with images of slimming results, positive testimonials and step-by-step guides for mixing or injecting at home.
After minutes of entering one group, a vendor posted WhatsApp details, where most purchases occur. The vendor sent an instruction manual and promised delivery within two days. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None asked about body mass, medical conditions or past usage.
Product Details and Pricing
Inside these communities, posts show black plastic packages with postal service stickers, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at home with sterile water, or ready-to-use injectors typically sold at 160 pounds for 20mg. When asked how long a injector should last, sellers give contradictory responses varying between a few weeks to “depends on your body”.
Service Oversight and Security Actions
A spokesperson for Telegram stated it actively moderated dangerous material on its service including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“Individuals are administering materials they cannot confirm. Even if the research behind this drug is valid, these digital products may not include what they claim,” stated Jason Murphy, the head of pharmacy at a pharmacy service.
A medical professional of an online medical service connected the increase in demand to recent price rises for approved weight-loss drugs such as Mounjaro. “With costs rising, individuals are turning to social media. But fake treatments are highly dangerous. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she explained.
Her staff has previously encountered patients harmed by personal administration from unverified sources. “We recognize the frustration, but purchasing from Telegram or WhatsApp is gambling with your health,” said Wyllie. “These substances could be contaminated or improperly measured.”
Manufacturer Statement
A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any government authority globally. “Consequently at this time no one can sell [it] for personal consumption,” they said, noting that any product “falsely representing itself as a company experimental substance not yet approved … may subject patients to potentially significant health risks”.
